Lazard Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,345
Closed -$78K 2640
2021
Q4
$78K Buy
25,345
+1,934
+8% +$6.51K ﹤0.01% 1541
2021
Q3
$84K Sell
23,411
-676
-3% -$2.55K ﹤0.01% 1473
2021
Q2
$86K Buy
24,087
+3,748
+18% +$13.2K ﹤0.01% 1397
2021
Q1
$79K Buy
20,339
+7,455
+58% +$30.8K ﹤0.01% 1263
2020
Q4
$54K Hold
12,884
﹤0.01% 1364
2020
Q3
$48K Buy
+12,884
New +$54.8K ﹤0.01% 1200
2015
Q2
Sell
-7,045
Closed -$73K 1234
2015
Q1
$73K Buy
7,045
+3,095
+78% +$42.3K ﹤0.01% 951
2014
Q4
$47K Sell
3,950
-2,170
-35% -$33K ﹤0.01% 1012
2014
Q3
$104K Buy
+6,120
New +$88.8K ﹤0.01% 876

Other funds holding BDSI

Lazard Asset Management's BDSI Position: Q1 2022 in Review

Lazard Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 25,345 shares — an estimated $78K sold.

Lazard Asset Management first reported a position in BDSI in Q3 2014 and held it in 9 quarters. The position peaked at $104K in Q3 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Lazard Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Lazard Asset Management sold 25,345 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $78K.
  • Lazard Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2014 and held it in 9 quarters.
  • Lazard Asset Management's BioDelivery Sciences International, Inc. position peaked at $104K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Lazard Asset Management's 13F filing for Q1 2022, filed 13 May 2022.